Vertex Pharmaceuticals
MA · 40 filings, 2025
What the money shows
Vertex Pharmaceuticals reported $5M in federal lobbying for 2025 across 40 filings. The filings name 10 lobbying firms, led by Marshall & POPP and Mclarty Inbound. The matched PAC file shows $43,000 to 0 lawmakers. The filing text lists 8 issue areas.
Sources: Senate LDA · FEC
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England. via Wikipedia ↗
1Lobbies on
Its filings list: Health Issues · Medicare/Medicaid · Taxation/Internal Revenue Code · Budget/Appropriations · Trade (domestic/foreign) · Medical/Disease Research/Clinical Labs · Pharmacy · Veterans
2Through these firms · 10
3Bills moving in its lanes
No bill names this company outright; these are recent bills in the sectors it lobbies.
- S 5236A bill to amend title XIX of the Social Security Act to ensure Medicaid coverage of mental health services…
- S 5225A bill to amend the Elementary and Secondary Education Act of 1965 to include certain curriculum expenses a…
- S 5227A bill to amend the Internal Revenue Code of 1986 to allow certain distributions from long-term qualified t…
- S 5232A bill to amend the Public Health Service Act to authorize rural residency planning and development grant p…
- S 5237A bill to require the Director of the National Institute of Allergy and Infectious Diseases to award a comp…